AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45

Authors: Wang, F Samudio, I Safe, S
Citation: F. Wang et al., Transcriptional activation of rat creatine kinase B by 17 beta-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites, J CELL BIOC, 84(1), 2002, pp. 156-172

Authors: Sanderson, JT Slobbe, L Lansbergen, GWA Safe, S van den Berg, M
Citation: Jt. Sanderson et al., 2,3,7,8-tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells, TOXICOL SCI, 61(1), 2001, pp. 40-48

Authors: Qin, CH Wilson, C Blancher, C Taylor, M Safe, S Harris, AL
Citation: Ch. Qin et al., Association of ARNT splice variants with estrogen receptor-negative breastcancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis, CLIN CANC R, 7(4), 2001, pp. 818-823

Authors: Yoon, K Pallaroni, L Stoner, M Gaido, K Safe, S
Citation: K. Yoon et al., Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements, J STEROID B, 78(1), 2001, pp. 25-32

Authors: Xie, W Duan, R Safe, S
Citation: W. Xie et al., Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor a crosstalk, J MOL ENDOC, 26(3), 2001, pp. 217-228

Authors: Porter, W Wang, F Duan, R Qin, C Castro-Rivera, E Kim, K Safe, S
Citation: W. Porter et al., Transcriptional activation of heat shock protein 27 gene expression by 17 beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists, J MOL ENDOC, 26(1), 2001, pp. 31-42

Authors: Safe, S
Citation: S. Safe, Molecular biology of the Ah receptor and its role in carcinogenesis, TOX LETT, 120(1-3), 2001, pp. 1-7

Authors: Chen, I Hsieh, T Thomas, T Safe, S
Citation: I. Chen et al., Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization, GENE, 262(1-2), 2001, pp. 207-214

Authors: Wang, F Samudio, I Safe, S
Citation: F. Wang et al., Transcriptional activation of cathepsin D gene expression by 17 beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition, MOL C ENDOC, 172(1-2), 2001, pp. 91-103

Authors: Safe, S
Citation: S. Safe, Sex ratios: Safe's response, ENVIR H PER, 109(6), 2001, pp. A251-A251

Authors: Safe, S
Citation: S. Safe, Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions, VITAM HORM, 62, 2001, pp. 231-252

Authors: Castro-Rivera, E Samudio, I Safe, S
Citation: E. Castro-rivera et al., Estrogen-regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements, J BIOL CHEM, 276(33), 2001, pp. 30853-30861

Authors: Duan, RQ Xie, W Burghardt, RC Safe, S
Citation: Rq. Duan et al., Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1, J BIOL CHEM, 276(15), 2001, pp. 11590-11598

Authors: Samudio, I Vyhlidal, C Wang, F Stoner, M Chen, I Kladde, M Barhoumi, R Burghardt, R Safe, S
Citation: I. Samudio et al., Transcriptional activation of deoxyribonucleic acid polymerase alpha gene expression in MCF-7 cells by 17 beta-estradiol, ENDOCRINOL, 142(3), 2001, pp. 1000-1008

Authors: McDougal, A Wormke, M Calvin, J Safe, S
Citation: A. Mcdougal et al., Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator, CANCER RES, 61(10), 2001, pp. 3902-3907

Authors: Lee, JE Safe, S
Citation: Je. Lee et S. Safe, Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells, BIOCH PHARM, 62(8), 2001, pp. 1113-1124

Authors: Lee, JE Safe, S
Citation: Je. Lee et S. Safe, 3 ',4 '-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells, TOXICOL SCI, 58(2), 2000, pp. 235-242

Authors: Safe, S
Citation: S. Safe, Bisphenol A and related endocrine disrupters, TOXICOL SCI, 56(2), 2000, pp. 251-252

Authors: Safe, S Wormke, M Samudio, I
Citation: S. Safe et al., Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells, J MAMMARY G, 5(3), 2000, pp. 295-306

Authors: Wormke, M Castro-Rivera, E Chen, I Safe, S
Citation: M. Wormke et al., Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells, J STEROID B, 72(5), 2000, pp. 197-207

Authors: Vyhlidal, C Samudio, I Kladde, MP Safe, S
Citation: C. Vyhlidal et al., Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site, J MOL ENDOC, 24(3), 2000, pp. 329-338

Authors: Xie, W Barwick, JL Simon, CM Pierce, AM Safe, S Blumberg, B Guzelian, PS Evans, RM
Citation: W. Xie et al., Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR, GENE DEV, 14(23), 2000, pp. 3014-3023

Authors: Yoon, K Pellaroni, L Ramamoorthy, K Gaido, K Safe, S
Citation: K. Yoon et al., Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines, MOL C ENDOC, 162(1-2), 2000, pp. 211-220

Authors: Gaido, KW Maness, SC McDonnell, DP Dehal, SS Kupfer, D Safe, S
Citation: Kw. Gaido et al., Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies, MOLEC PHARM, 58(4), 2000, pp. 852-858

Authors: Saville, B Wormke, M Wang, F Nguyen, T Enmark, E Kuiper, G Gustafsson, JA Safe, S
Citation: B. Saville et al., Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements, J BIOL CHEM, 275(8), 2000, pp. 5379-5387
Risultati: 1-25 | 26-45